NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA L’ORÉAL SUCCESSFULLY PRICES A 1.5 BILLION EURO DUAL TRANCHE BOND Clichy, 16 November 2023 – L’Oréal today announces that it has successfully priced a public bond offering for an aggregate nominal amount of €1.5 billion. The offering is composed of two tranches: - A €800 million long 3-year fixed rate bond paying a coupon of 3.375 % p.a. - A €700 million 6-year fixed rate
L’ORÉAL CELEBRATES 10 YEARS OF ITS ‘SHARE & CARE’ SOCIAL INNOVATION AND EMPLOYEE BENEFITS PROGRAM Introduces new benefits to support employees with cancer and promote mental health Clichy, 16 November 2023 – L’Oréal today recognized the ten-year anniversary of Share & Care, the social innovation and employee benefits program launched in 2013 that today serves the Groupe’s employees around the world. Since its launch, Share & Care has ensured that all L’Oréal employees enjoy social protections of
A federal judge on Monday allowed the majority of claims to move forward in sprawling litigation that claims chemical hair relaxer products made by L'Oreal USA, Revlon and others cause cancer and other injuries. Illinois-based U.S. District Judge Mary Rowland denied most of the companies’ arguments in their motion to dismiss the complaint in the multidistrict litigation over the products. Of the 15 counts in the complaint, Rowland dismissed three entirely and a portion of a fourth, finding the plaintiffs had not done enough to bolster their claims that the companies committed fraud.